STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud

The U.S. Justice Department has issued a new directive to combat white-collar fraud, specifically targeting violations of the Federal Food, Drug, and Cosmetic Act, which regulates the pharmaceutical industry.

The directive aims to strengthen the department's efforts to hold pharmaceutical companies accountable for misconduct and fraudulent practices.